Plattsburgh, NY, 2018-Jun-25 — /EPR Network/ — Post-operative pulmonary complications (PPCs) are a major burden to the healthcare system. A new real-world study published in [read full press release…]
Two new publications build on previous evidence that not all devices are equally effective in delivering asthma control. Plattsburgh, NY, 2018-Feb-01 — /EPR Network/ — [read full press release…]
Monaghan Medical Corporation understands that for those with asthma, particularly children, choosing the device that best delivers their medication is an important consideration. Plattsburgh, NY, [read full press release…]
Aerobika® OPEP device proves to be a cost-effective treatment option in the management of post-exacerbation COPD patients. Plattsburgh, NY, 2017-Nov-11 — /EPR Network/ — The [read full press release…]
Designation recognizes products that bring improvements to the health care industry. Plattsburgh, NY, 2017-Oct-23 — /EPR Network/ — Monaghan Medical Corporation announced its AEROBIKA® Oscillating [read full press release…]
This latest study adds to the growing base of evidence that demonstrates Monaghan’s drug-free Aerobika® device is effective for lung health maintenance. Syracuse, NY, 2017-Jan-17 [read full press release…]
